Categories
Prostate cancer

Developing machine learning algorithms for dynamic estimation of progression during active surveillance for prostate cancer

  • Cai, Q. et al. Estimates of over-time trends in incidence and mortality of prostate cancer from 1990 to 2030. Transl. Androl. Urol. Apr 9, 196–209 (2020).

    Article 

    Google Scholar
     

  • Liu, Y., Hall, I. J., Filson, C. & Howard, D. H. Trends in the use of active surveillance and treatments in Medicare beneficiaries diagnosed with localized prostate cancer. Urol. Oncol. 39, 432.e1–432.e10 (2021).

    Article 

    Google Scholar
     

  • Willemse, P. M. et al. Systematic review of active surveillance for clinically localised prostate cancer to develop recommendations regarding inclusion of intermediate-risk disease, biopsy characteristics at inclusion and monitoring, and surveillance repeat biopsy strategy. Eur. Urol. 81, 337–346 (2022).

    Article 

    Google Scholar
     

  • Gnanapragasam, V. J. et al. Using prognosis to guide inclusion criteria, define standardised endpoints and stratify follow-up in active surveillance for prostate cancer. BJU Int. 124, 758–767 (2019).

    CAS 
    Article 

    Google Scholar
     

  • Drost, F. H., Nieboer, D., Morgan, T. M., Carroll, P. R. & Roobol, M. J. Movember Foundation’s Global Action Plan Prostate Cancer Active Surveillance (GAP) consortium. Predicting biopsy outcomes during active surveillance for prostate cancer: external validation of the canary prostate active surveillance study risk calculators in five large active surveillance cohorts. Eur. Urol. 76, 693–702 (2019).

    Article 

    Google Scholar
     

  • Tomer, A. et al. Movember Foundation’s Global Action Plan Prostate Cancer Active Surveillance (GAP3) consortium. Personalised biopsy schedules based on risk of Gleason upgrading for patients with low-risk prostate cancer on active surveillance. BJU Int. 127, 96–107 (2021).

    Article 

    Google Scholar
     

  • Cooperberg, M. R. et al. Tailoring intensity of active surveillance for low-risk prostate cancer based on individualized prediction of risk stability. JAMA Oncol. 6, e203187 (2020).

    Article 

    Google Scholar
     

  • Thurtle, D. R., Jenkins, V., Pharoah, P. D. & Gnanapragasam, V. J. Understanding of prognosis in non-metastatic prostate cancer: a randomised comparative study of clinician estimates measured against the PREDICT prostate prognostic model. Br. J. Cancer 121, 715–718 (2019).

    Article 

    Google Scholar
     

  • Chen, Q. F. et al. Surveillance strategy after complete ablation of initial recurrent hepatocellular carcinoma: a risk-based machine learning study. J. Vasc. Inter. Radio. 32, 1548–1557.e2 (2021).

    Article 

    Google Scholar
     

  • Miller, H. A. et al. Evaluation of disease staging and chemotherapeutic response in non-small cell lung cancer from patient tumor-derived metabolomic data. Lung Cancer 156, 20–30 (2021).

    Article 

    Google Scholar
     

  • Wang, L. et al. Development and validation of a Deep Learning Algorithm for Mortality Prediction in Selecting Patients With Dementia for Earlier Palliative Care Interventions. JAMA Netw. Open 2, e196972 (2019).

    Article 

    Google Scholar
     

  • Jones, O. T. et al. Artificial intelligence techniques that may be applied to primary care data to facilitate earlier diagnosis of cancer: systematic review. J. Med Internet Res 23, e23483 (2021).

    Article 

    Google Scholar
     

  • Tran, K. A. et al. Deep learning in cancer diagnosis, prognosis and treatment selection. Genome Med 27, 152 (2021).

    Article 

    Google Scholar
     

  • Thurtle, D. et al. Progression and treatment rates using an active surveillance protocol incorporating image-guided baseline biopsies and multiparametric magnetic resonance imaging monitoring for men with favourable-risk prostate cancer. BJU Int 122, 59–65 (2018).

    CAS 
    Article 

    Google Scholar
     

  • Caglic, I. et al. MRI-derived PRECISE scores for predicting pathologically-confirmed radiological progression in prostate cancer patients on active surveillance. Eur. Radio. 31, 2696–2705 (2021).

    Article 

    Google Scholar
     

  • Moore, C. M. et al. Reporting magnetic resonance imaging in men on active surveillance for prostate cancer: the PRECISE recommendations-A report of a European school of oncology task force. Eur. Urol. 71, 648–655 (2017).

    Article 

    Google Scholar
     

  • Merriel, S. W. D. et al. Prostate cancer UK expert reference group on active surveillance. Best practice in active surveillance for men with prostate cancer: a Prostate Cancer UK consensus statement. BJU Int 1, 47–54 (2019). 2019.

    Article 

    Google Scholar
     

  • Nayan, M. et al. A machine learning approach to predict progression on active surveillance for prostate cancer. Urol. Oncol. 40, 161.e1–161.e7 (2022).

    Article 

    Google Scholar
     

  • Venderbos, L. D., Luiting, H., Hogenhout, R. & Roobol, M. J. Interaction of MRI and active surveillance in prostate cancer: Time to re-evaluate the active surveillance inclusion criteria. Urol. Oncol. S1078-1439, 00367–7 (2021).


    Google Scholar
     

  • Pavlou, M. et al. How to develop a more accurate risk prediction model when there are few events. BMJ 8, 353:i3235 (2016).


    Google Scholar
     

  • Van Hemelrijck, M. et al. Members of the movember foundation’s global action plan prostate cancer active surveillance GAP3 consortium; members of the movember foundation’s global action plan prostate cancer active surveillance GAP3 consortium. Reasons for discontinuing active surveillance: assessment of 21 centres in 12 countries in the movember GAP3 consortium. Eur. Urol. 75, 523–531 (2019).

    Article 

    Google Scholar
     

  • Philippou, Y., Raja, H. & Gnanapragasam, V. J. Active surveillance of prostate cancer: a questionnaire survey of urologists, clinical oncologists and urology nurse specialists across three cancer networks in the United Kingdom. BMC Urol. 13, 15:52 (2015).


    Google Scholar
     

  • Lee, C., Yoon, J. & Schaar, M. V. Dynamic-deephit: A deep learning approach for dynamic survival analysis with competing risks based on longitudinal data. IEEE Trans. Biomed. Eng. 67, 122–133 (2020).

    Article 

    Google Scholar
     

  • Hosmer, D. W., Lemeshow, S. & May, S. Applied Survival Analysis: Regression Modelling of Time-to-Event Data. (John Wiley & Sons, New York 2008).

  • Uno, H., Cai, T., Pencina, M. J., D’Agostino, R. B. & Wei, L. J. On the C-statistics for evaluating overall adequacy of risk prediction procedures with censored survival data. Stat. Med. 10, 1105–17 (2011).

    Article 

    Google Scholar
     

  • Lee, C. & van der Schaar, M. Temporal phenotyping using deep predictive clustering of disease progression. Proc. 37th Int. Conf. Mach. Learn. 535, 5767–5777 (2020).


    Google Scholar
     

  • Leave a Reply